Operating Margin of Esperion Therapeutics, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Esperion Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Esperion Therapeutics, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -9.7%, a 274% decline year-over-year.
  • Esperion Therapeutics, Inc. annual Operating Margin for 2024 was 16%.
  • Esperion Therapeutics, Inc. annual Operating Margin for 2023 was -134%, a 44% increase from 2022.
  • Esperion Therapeutics, Inc. annual Operating Margin for 2022 was -238%, a 18% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Esperion Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -9.7% -15% -274% 01 Jul 2025 30 Sep 2025
Q2 2025 -13% -15% -842% 01 Apr 2025 30 Jun 2025
Q1 2025 -15% -0.3% -2% 01 Jan 2025 31 Mar 2025
Q4 2024 16% +150% 01 Oct 2024 31 Dec 2024
Q3 2024 5.6% +157% 01 Jul 2024 30 Sep 2024
Q2 2024 1.8% +195% 01 Apr 2024 30 Jun 2024
Q1 2024 -15% +214% +93% 01 Jan 2024 31 Mar 2024
Q4 2023 -134% +104% +44% 01 Oct 2023 31 Dec 2023
Q3 2023 -151% +116% +43% 01 Jul 2023 30 Sep 2023
Q2 2023 -193% +113% +37% 01 Apr 2023 30 Jun 2023
Q1 2023 -229% -19% -9.2% 01 Jan 2023 31 Mar 2023
Q4 2022 -238% +51% +18% 01 Oct 2022 31 Dec 2022
Q3 2022 -267% +100% +27% 01 Jul 2022 30 Sep 2022
Q2 2022 -306% +163% +35% 01 Apr 2022 30 Jun 2022
Q1 2022 -209% -154% -277% 01 Jan 2022 31 Mar 2022
Q4 2021 -289% -236% -442% 01 Oct 2021 31 Dec 2021
Q3 2021 -367% -328% -847% 01 Jul 2021 30 Sep 2021
Q2 2021 -469% -437% -1348% 01 Apr 2021 30 Jun 2021
Q1 2021 -56% +5263% +99% 01 Jan 2021 31 Mar 2021
Q4 2020 -53% +9.4% +15% 01 Oct 2020 31 Dec 2020
Q3 2020 -39% 01 Jul 2020 30 Sep 2020
Q2 2020 -32% 01 Apr 2020 30 Jun 2020
Q1 2020 -5318% 01 Jan 2020 31 Mar 2020
Q4 2019 -63% 01 Oct 2019 31 Dec 2019

Esperion Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 16% +150% 01 Jan 2024 31 Dec 2024
2023 -134% +104% +44% 01 Jan 2023 31 Dec 2023
2022 -238% +51% +18% 01 Jan 2022 31 Dec 2022
2021 -289% -236% -442% 01 Jan 2021 31 Dec 2021
2020 -53% +9.4% +15% 01 Jan 2020 31 Dec 2020
2019 -63% 01 Jan 2019 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.